ProShare Advisors LLC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,843
-58.4%
11,069
+0.7%
0.00%
Q2 2023$28,482
-33.2%
10,997
+5.3%
0.00%
Q1 2023$42,624
-29.0%
10,447
-12.7%
0.00%
Q4 2022$60,044
-58.6%
11,961
+7.4%
0.00%
-100.0%
Q3 2022$145,000
+6.6%
11,138
+5.3%
0.00%
Q2 2022$136,000
-36.2%
10,576
-24.2%
0.00%
Q1 2022$213,000
-32.6%
13,949
-21.8%
0.00%
-100.0%
Q4 2021$316,000
-26.9%
17,830
-13.3%
0.00%0.0%
Q3 2021$432,000
-0.5%
20,562
-6.6%
0.00%0.0%
Q2 2021$434,000
-12.5%
22,012
+29.1%
0.00%
-50.0%
Q1 2021$496,000
+2.7%
17,050
+7.0%
0.00%0.0%
Q4 2020$483,000
+116.6%
15,931
+13.7%
0.00%
+100.0%
Q3 2020$223,000
-19.8%
14,013
-0.5%
0.00%0.0%
Q2 2020$278,000
+112.2%
14,081
+32.7%
0.00%0.0%
Q1 2020$131,000
-60.1%
10,611
-40.1%
0.00%
-50.0%
Q4 2019$328,00017,7230.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Greenspring Associates, LLC 1,573,357$47,665,00061.89%
RHO CAPITAL PARTNERS INC 3,766,666$114,111,00060.06%
Column Group LLC 15,396,116$466,502,00042.31%
Ponoi II Management, LLC 1,298,908$39,357,00028.68%
Ponoi Management, LLC 1,298,908$39,357,00022.52%
Euclidean Capital LLC 2,083,602$63,133,00013.36%
Aquilo Capital Management, LLC 1,005,534$30,463,0006.33%
Octagon Capital Advisors LP 75,227$2,279,0000.79%
Jasper Ridge Partners, L.P. 308,750$9,354,0000.41%
Point72 Asset Management, L.P. 1,761,157$53,354,0000.26%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders